Momentum Biotechnologies Completes Acquisition of OmicScouts
With this transaction, Momentum gains access to a broad portfolio of well-validated proteomic assays that enhance and extend their existing service offerings, enabling clients to seamlessly progress from high-throughput screening into cell-based assays, as well as to discover new targets and biomarkers.
Biomarkers | 11/03/2025 | By Aishwarya
Abbott Announces Availability of Lingo Continuous Glucose Monitor in US
Lingo is based on Abbott's world-leading FreeStyle Libre continuous glucose monitoring technology, now used by more than 6 million people with diabetes globally.
Biomarkers | 06/09/2024 | By Aishwarya | 298
Inoviv Introduces MasterKey for Multiplexed Targeted Protein Assays
Inoviv has developed MasterKey, which enables researchers to select specific proteins from a comprehensive, pre-characterized catalog of thousands of proteins.
Biomarkers | 01/08/2024 | By Aishwarya | 191
Nordic Bioscience, Roche Diagnostics strengthen collaboration for development of biomarkers
Nordic Bioscience will transfer unique and proprietary blood-based biomarkers to Roche Diagnostics to be implemented on the automated COBAS platform<br />
Biomarkers | 17/06/2022 | By Sudeep Soparkar | 609
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy